Commercialization UX support for Samsung Health to integrate reliable medicine data from trusted partner with Samsung Health application.
Provided India-region–centric UX support for the Medication feature by defining India Deltas and adapting global Samsung Health guidelines to local needs.
Supported partner integration with TATA 1mg, enabling reliable medicine data from one of India’s largest inventories, while ensuring clarity & consistency.
Since its initial rollout in 2022, the feature has grown to support over 1.6 million monthly active devices, generating 2+ million medication-related interactions per month by 2025.